Inspection prep notes · Laboratory
Analytical method validation
Also called: method validation, method verification, analytical method
FDA looks less at whether a test method is written down than at whether data show the method is suitable for testing the product in question. The findings below are quoted from warning letters and FDA 483s.
What inspectors cited
1Test methods in use were not validated
Based on the records and information you provided, your firm failed to perform test method validation (or verification if compendial testing is used) for each test method used for drugs distributed to the United States.
FDA Warning Letter · Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd. · 2026-08-18 · View document
In addition, the non-USP in-house test method used for Gas Chromatography (GC) purity testing has not been validated.
FDA 483 · Unilab Chemicals and Pharmaceuticals Private Ltd. · 2026-10-22 · View document
2Method verification was not performed
Furthermore, in 2025, your firm shipped (b)(4) lots of tirzepatide API drugs (about (b)(4) total weight) without completing method verification for the bacterial endotoxin test.
FDA Warning Letter · Harbin Jixianglong Biotech Co., Ltd. · 2026-05-19 · View document
Specifically, Your firm has not established or documented method verification studies for the USP compendial assay and residual solvent test methods used for [redacted] USP API.
FDA 483 · Shimoga Chemicals · 2026-10-23 · View document
3Microbiological test methods for finished products were not validated
Your non-compendial test method used to determine microbiological attributes (e.g., total count, objectionable microorganisms) for your finished OTC drug product was inadequate. Specifically, you lacked appropriate incubation times, lacked appropriate method suitability, and lacked positive and negative controls. In addition, you did not validate this non-compendial method.
FDA Warning Letter · Suretec Innovations, LLC · 2026-08-18 · View document
Additionally, none of the microbiological test methods used for finished product release testing, including total microbial enumeration testes (aerobic microbial count, total yeast and mold count), and testing for the absence of specified microorganisms, including, but not limited to, staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans have been validated or verified for any OTC drug product.
FDA 483 · Blossom Pharmaceuticals · 2026-10-22 · View document
4System suitability was not adequately determined before testing
Your firm did not adequately perform system suitability testing for laboratory equipment before testing your (b)(4) and other critical samples.
FDA Warning Letter · K.C. Pharmaceuticals, Inc. · 2026-08-18 · View document
Your high-performance liquid chromatography (HPLC) analyses for (b)(4) Assay Content lacked an appropriate determination of system suitability, as outlined in USP <621>, before sample injections.
FDA Warning Letter · Taizhou Kangping Medical Science and Technology Co., Ltd. · 2025-11-11
5The accuracy and specificity of test methods were not demonstrated
Your analytical method does not demonstrate specificity, accuracy, precision, and robustness.
FDA Warning Letter · Respilon Production S.R.O. · 2026-05-05 · View document
The accuracy, sensitivity, specificity and reproducibility of test methods have not been established and documented.
FDA 483 · Hybrid Pharma LLC · 2026-11-13 · View document
Questions to check against your procedures
- Is there validation data for each test method used for drugs distributed to the United States?
- Are in-house test methods validated before they are used for testing?
- Have verification studies been established and documented for compendial test methods?
- Are the microbiological methods used for finished product release validated or verified for each product?
- Do microbiological methods have incubation times, method suitability, and positive and negative controls in place?
- Is system suitability determined before samples are tested?
Compiled by AI from public findings and checked by a person. Quotations are verbatim from the original documents; (b)(4) marks text redacted in the original. As of 2026-11-15.